Adage Capital Partners Gp, L.L.C. Milestone Pharmaceuticals Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$1.7 - $22.5 $1.02 Million - $13.5 Million	-600,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$15.4 - $21.9 $1.54 Million - $2.19 Million	100,000 Added 20.0%	600,000 $9.61 Million
Q3 2019 Nov 14, 2019	BUY	$15.67 - $25.96 $4.07 Million - $6.75 Million	260,000 Added 108.33%	500,000 $9.33 Million
Q2 2019 Aug 14, 2019	BUY	$15.37 - $27.15 $3.69 Million - $6.52 Million	240,000 New	240,000 $6.52 Million

28.7M

200

Ticker MIST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,010,900
Market Cap $55.5M
Description
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.